| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 1 | 2024 | Proportion of treatment effect explained: An overview of interpretations | Stijven, Florian; ALONSO ABAD, Ariel; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 2 | 2024 | A joint penalized spline smoothing model for the number of positive and negative COVID-19 tests | De Witte , Dries; ALONSO ABAD, Ariel; NEYENS, Thomas; VERBEKE, Geert; MOLENBERGHS, Geert; Ortore, Maria Grazia | Journal Contribution | A1 |
| 3 | 2024 | An information‐theoretic approach for the assessment of a continuous outcome as a surrogate for a binary true endpoint based on causal inference: Application to vaccine evaluation | ALONSO ABAD, Ariel; ONG, Fenny; Stijven, Florian; VAN DER ELST, Wim; MOLENBERGHS, Geert; VAN KEILEGOM, Ingrid; VERBEKE, Geert; Callegaro, Andrea | Journal Contribution | A1 |
| 4 | 2023 | A multivariate spatio-temporal model for the incidence of imported COVID-19 cases and COVID-19 deaths in Cuba | De Witte , Dries; ALONSO ABAD, Ariel; MOLENBERGHS, Geert; VERBEKE, Geert; SANCHEZ, Lizet; Mas-Bermejo, Pedro; NEYENS, Thomas | Journal Contribution | A1 |
| 5 | 2022 | A New Cost-Benefit Economic Model Approach of Hemodialyzer Reuse | Torres, Jeamichel; Sariol, Harold; YPERMAN, Jan; ADRIAENSENS, Peter; CARLEER, Robert; VANREPPELEN, Kenny; Peacok, Thayset; Ramos, Yoandri; Sauvanell, Ángel; ALONSO ABAD, Ariel | Journal Contribution | A2 |
| 6 | 2022 | Identifying individual predictive factors for treatment efficacy | ALONSO ABAD, Ariel; VAN DER ELST, Wim; SANCHEZ, Lizet; Luaces, Patricia; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 7 | 2022 | Implementing the meta-analytic approach for the evaluation of surrogate endpoints in SAS and R: a word of caution | ONG, Fenny; Wang, Jingzhao; VAN DER ELST, Wim; VERBEKE, Geert; MOLENBERGHS, Geert; ALONSO ABAD, Ariel | Journal Contribution | A1 |
| 8 | 2021 | Evaluation of surrogate endpoints | MOLENBERGHS, Geert; SHKEDY, Ziv; BURZYKOWSKI, Tomasz; BUYSE, Marc; ALONSO ABAD, Ariel; VAN DER ELST, Wim | Book Section | B2 |
| 9 | 2021 | The individual-level surrogate threshold effect in a causal-inference setting with normally distributed endpoints | VAN DER ELST, Wim; ALONSO ABAD, Ariel; Coppenolle, Hans; MEYVISCH, Paul; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 10 | 2020 | Meta-analytic approach to evaluation of surrogate endpoints | BURZYKOWSKI, Tomasz; BUYSE, Marc; MOLENBERGHS, Geert; ALONSO ABAD, Ariel; VAN DER ELST, Wim; SHKEDY, Ziv | Book Section | B2 |
| 11 | 2020 | Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients | Lorenzo-Luaces, Patricia; SANCHEZ, Lizet; Saavedra, Danay; Crombet, Tania; VAN DER ELST, Wim; ALONSO ABAD, Ariel; MOLENBERGHS, Geert; Lage, Agustin | Journal Contribution | A1 |
| 12 | 2020 | Generating random correlation matrices with fixed values: An application to the evaluation of multivariate surrogate endpoints | FLOREZ POVEDA, Alvaro; ALONSO ABAD, Ariel; MOLENBERGHS, Geert; VAN DER ELST, Wim | Journal Contribution | A1 |
| 13 | 2020 | On the relationship between association and surrogacy when both the surrogate and true endpoint are binary outcomes | MEYVISCH, Paul; ALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 14 | 2019 | A reflection on the possibility of finding a good surrogate | ALONSO ABAD, Ariel; MEYVISCH, Paul; VAN DER ELST, Wim; MOLENBERGHS, Geert; VERBEKE, Geert | Journal Contribution | A1 |
| 15 | 2019 | A reflection on the causal interpretation of individual-level surrogacy | ALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert; Florez, Alvaro J. | Journal Contribution | A1 |
| 16 | 2018 | Statistical evaluation of surrogate endpoints in cancer clinical trials | BUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, K.; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz | Book Section | B2 |
| 17 | 2018 | Predictive biomarkers of treatment success in advanced non-small cell lung cancer patients using multivariate causal inference. | Lorenzo-Luaces, P.; Saavedra, D.; VAN DER ELST, Wim; ALONSO ABAD, Ariel; Viada Gonzalez, C.; SANCHEZ, Lizet | Journal Contribution | M |
| 18 | 2018 | Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial | MEYVISCH, Paul; Kambili, Chrispin; Andries, Koen; Lounis, Nacer; Theeuwes, Myriam; Dannemann, Brian; Vandebosch, An; VAN DER ELST, Wim; MOLENBERGHS, Geert; ALONSO ABAD, Ariel | Journal Contribution | A1 |
| 19 | 2018 | A maximum entropy approach for the evaluation of surrogate endpoints based on causal inference | ALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 20 | 2017 | The R Package Surrogate | VAN DER ELST, Wim; ALONSO ABAD, Ariel; MOLENBERGHS, Geert | Book Section | B2 |
| 21 | 2017 | Applied Surrogate Endpoint Evaluation Methods with SAS and R | ALONSO ABAD, Ariel; BIGIRUMURAME, Theophile; BURZYKOWSKI, Tomasz; BUYSE, Marc; MOLENBERGHS, Geert; MUCHENE, Leacky; PERUALILA, Nolen Joy; SHKEDY, Ziv; VAN DER ELST, Wim | Book | B1 |
| 22 | 2016 | Statistical evaluation of surrogate endpoints with examples from cancer clinical trials | BUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, Koji; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 23 | 2016 | Exploring the relationship between the causal-inference and meta-analytic paradigms for the evaluation of surrogate endpoints | VAN DER ELST, Wim; MOLENBERGHS, Geert; ALONSO ABAD, Ariel | Journal Contribution | A1 |
| 24 | 2015 | Biomarker‑based surrogate endpoints | BUYSE, Marc; BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; ALONSO ABAD, Ariel | Book Section | B2 |
| 25 | 2015 | Validating predictors of therapeutic success: A causal inference approach | ALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 26 | 2015 | On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpoints | ALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 27 | 2015 | Reliability Measures In Item Response Theory: Manifest Versus Latent Correlation Functions | MILANZI, Elasma; MOLENBERGHS, Geert; ALONSO ABAD, Ariel; VERBEKE, Geert; De Boeck, Paul | Journal Contribution | A1 |
| 28 | 2015 | Impact of selection bias on the evaluation of clusters of chemical compounds in the drug discovery process. | MILANZI, Elasma; ALONSO ABAD, Ariel; MOLENBERGHS, Geert; Buyck, Christophe; BIJNENS, Luc | Journal Contribution | A1 |
| 29 | 2015 | Estimation after a group sequential trial | MILANZI, Elasma; MOLENBERGHS, Geert; ALONSO ABAD, Ariel; Kenward, M.G.; Tsiatis, A.A.; Davidian, M.; VERBEKE, Geert | Journal Contribution | A1 |
| 30 | 2015 | A new modeling approach for quantifying expert opinion in the drug discovery process | MILANZI, Elasma; ALONSO ABAD, Ariel; MOLENBERGHS, Geert; Buyck, Christophe; BIJNENS, Luc | Journal Contribution | A1 |
| 31 | 2014 | Estimation After a Group Sequential Trial | MILANZI, Elasma; MOLENBERGHS, Geert; ALONSO ABAD, Ariel; Kenward, Michael G; Tsiatis, Anastasios A; Davidian, Marie; VERBEKE, Geert | Working Paper | R2 |
| 32 | 2014 | Impact of selection bias on the evaluation of clusters of chemical compounds in the drug discovery process | ALONSO ABAD, Ariel; MILANZI, Elasma; MOLENBERGHS, Geert; Buyck, Christophe; BIJNENS, Luc | Working Paper | R2 |
| 33 | 2014 | Statistical Validation of Surrogate Markers in Clinical Trials | ALONSO ABAD, Ariel; MOLENBERGHS, Geert; Van Breukelen, Gerard | Book Section | B2 |
| 34 | 2014 | A permutational-splitting sample procedure to quantify expert opinion on clusters of chemical compounds using high-dimensional data | MILANZI, Elasma; ALONSO ABAD, Ariel; Buyck, Christophe; MOLENBERGHS, Geert; BIJNENS, Luc | Journal Contribution | A1 |
| 35 | 2013 | Statistical evaluation of surrogate endpoints in clinical studies | MOLENBERGHS, Geert; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz; BUYSE, Marc | Book Section | B2 |
| 36 | 2013 | Review: Clinical Trial Methodology: Surrogate endpoints: when should they be used? | MOLENBERGHS, Geert; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 37 | 2012 | Ignoring overdispersion in hierarchical loglinear models: Possible problems and solutions | MILANZI, Elasma; ALONSO ABAD, Ariel; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 38 | 2011 | An information-theoretic approach to surrogate-marker evaluation with failure time endpoints | Pryseley, Assam; Tilahun, Abel; ALONSO ABAD, Ariel; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 39 | 2010 | The Functional Living Index-Cancer: estimating its reliability based on clinical trial data | LAENEN, Annouschka; ALONSO ABAD, Ariel | Journal Contribution | A1 |
| 40 | 2010 | Testing for misspecification in generalized linear mixed models | ALONSO ABAD, Ariel; LITIERE, Saskia; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 41 | 2010 | A unified framework for the evaluation of surrogate endpoints in mental-health clinical trials | MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel; ASSAM NKOUIBERT, Pryseley; Tilahun, Abel; BUYSE, Marc | Journal Contribution | A1 |
| 42 | 2010 | Genomic Biomarkers for Depression: Feature-Specific and Joint Biomarkers | TILAHUN ESHETE, Abel; LIN, Dan; SHKEDY, Ziv; GEYS, Helena; ALONSO ABAD, Ariel; Peeters, Pieter; TALLOEN, Willem; Drinkenburg, Wilhelmus; Goehlmann, Hinrich; Gorden, Evian; BIJNENS, Luc; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 43 | 2010 | The impact of a misspecified random-effects distribution on the estimation and the performance of inferential procedures in generalized linear mixed models (vol 27, pg 3125, 2008) | LITIERE, Saskia; ALONSO ABAD, Ariel; MOLENBERGHS, Geert | Journal Contribution | M |
| 44 | 2010 | Coping With Memory Effect and Serial Correlation When Estimating Reliability in a Longitudinal Framework | LAENEN, Annouschka; ALONSO ABAD, Ariel; MOLENBERGHS, Geert; VANGENEUGDEN, Tony; Mallinckrodt, Craig H. | Journal Contribution | A1 |
| 45 | 2010 | Using earlier measures in a longitudinal sequence as a potential surrogate for a later one | ASSAM NKOUIBERT, Pryseley; TILAHUN ESHETE, Abel; ALONSO ABAD, Ariel; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 46 | 2010 | A Unified Approach to Multi-item Reliability | ALONSO ABAD, Ariel; LAENEN, Annouschka; MOLENBERGHS, Geert; GEYS, Helena; VANGENEUGDEN, Tony | Journal Contribution | A1 |
| 47 | 2009 | Investigating Association Between Behavior, Corticosterone, Heart Rate, and Blood Pressure in Rats Using Surrogate Marker Evaluation Methodology | TILAHUN ESHETE, Abel; MARINGWA, John; GEYS, Helena; ALONSO ABAD, Ariel; Raeymaekers, Leen; MOLENBERGHS, Geert; Van Den Kieboom, Gerd; Drinkenburg, Pim; BIJNENS, Luc | Journal Contribution | A1 |
| 48 | 2009 | A comparative evaluation of Cone Beam Computed Tomography (CBCT) and Multi-Slice CT (MSCT) Part I. On subjective image quality. | LIANG, Xin; Jacobs, R.; Hassan, B.; Li, L.; Pauwels, R.; Corpas, L.; Souza, P.C.; MARTENS, Wendy; Shahbazian, M.; ALONSO ABAD, Ariel; LAMBRICHTS, Ivo | Journal Contribution | A1 |
| 49 | 2009 | A family of measures to evaluate scale reliability in a longitudinal setting | LAENEN, Annouschka; ALONSO ABAD, Ariel; MOLENBERGHS, Geert; VANGENEUGDEN, Tony | Journal Contribution | A1 |
| 50 | 2009 | Reliability of a longitudinal sequence of scale ratings. | LAENEN, Annouschka; ALONSO ABAD, Ariel; MOLENBERGHS, Geert; VANGENEUGDEN, Tony | Journal Contribution | A1 |
| 51 | 2009 | Evaluation of Biomarkers for Pharmacological Activity | ALONSO ABAD, Ariel; MOLENBERGHS, Geert; RENARD, Didier; Darstein, Christelle | Journal Contribution | A1 |
| 52 | 2009 | Using longitudinal data from a clinical trial in depression to assess the reliability of its outcome scales | LAENEN, Annouschka; ALONSO ABAD, Ariel; MOLENBERGHS, Geert; Mallinckrodt, Craig H.; VANGENEUGDEN, Tony | Journal Contribution | A1 |
| 53 | 2008 | Reliability of a longitudinal sequence of scale ratings | LAENEN, Annouschka; ALONSO ABAD, Ariel; MOLENBERGHS, Geert; VANGENEUGDEN, Tony | Proceedings Paper | C1 |
| 54 | 2008 | Evaluating time to cancer recurrence as a surrogate marker for survival from an information theory perspective | ALONSO ABAD, Ariel; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 55 | 2008 | Surrogate end points: hopes and perils | ALONSO ABAD, Ariel; MOLENBERGHS, Geert | Journal Contribution | A3 |
| 56 | 2008 | Information theory-based surrogate marker evaluation from several randomized clinical trials with binary endpoints, using SAS | TILAHUN ESHETE, Abel; ASSAM NKOUIBERT, Pryseley; ALONSO ABAD, Ariel; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 57 | 2008 | The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials | MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel; ASSAM NKOUIBERT, Pryseley; TILAHUN ESHETE, Abel; BUYSE, Marc | Journal Contribution | A1 |
| 58 | 2008 | A family of tests to detect misspecifications in the random-effects structure of generalized linear mixed models | ALONSO ABAD, Ariel; LITIERE, Saskia; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 59 | 2008 | The impact of a misspecified random-effects distribution on the estimation and the performance of inferential procedures in generalized linear mixed models | LITIERE, Saskia; ALONSO ABAD, Ariel; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 60 | 2007 | Generalizability in non-Gaussian longitudinal clinical trial data based on generalized linear mixed models | VANGENEUGDEN, Tony; MOLENBERGHS, Geert; LAENEN, Annouschka; ALONSO ABAD, Ariel; GEYS, Helena | Journal Contribution | A1 |
| 61 | 2007 | Type I and type II error under random-effects misspecification in generalized linear mixed models | LITIERE, Saskia; ALONSO ABAD, Ariel; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 62 | 2007 | Information-theory based surrogate marker evaluation from several randomized clinical trials with continuous true and binary surrogate endpoints | ASSAM NKOUIBERT, Pryseley; TILAHUN ESHETE, Abel; ALONSO ABAD, Ariel; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 63 | 2007 | Flexible surrogate marker evaluation from several randomized clinical trials with continuous endpoints, using R and SAS | TILAHUN ESHETE, Abel; Pryseley, Assam; ALONSO ABAD, Ariel; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 64 | 2007 | A measure for the reliability of a rating scale based on longitudinal clinical trial data | LAENEN, Annouschka; ALONSO ABAD, Ariel; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 65 | 2006 | Surrogate Marker Evaluation from an Information Theory Perspective | ALONSO ABAD, Ariel; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 66 | 2006 | A unifying approach for surrogate marker validation based on Prentice's criteria | ALONSO ABAD, Ariel; MOLENBERGHS, Geert; GEYS, Helena; BUYSE, Marc; VANGENEUGDEN, Tony | Journal Contribution | A1 |
| 67 | 2005 | Repeated measures and surrogate endpoint validation | ALONSO ABAD, Ariel; GEYS, Helena; VANGENEUGDEN, Tony | Book Section | B3 |
| 68 | 2005 | Surrogate marker validation in mental health | VANGENEUGDEN, Tony; ALONSO ABAD, Ariel; GEYS, Helena; LAENEN, Annouschka | Book Section | B2 |
| 69 | 2004 | Investigating validity of psychiatric symptom scales and surrogate market | ALONSO ABAD, Ariel | Theses and Dissertations | T1 |
| 70 | 2004 | Prentice's approach and the meta-analytic paradigm: a reflection on the role of statistics in the evaluation of surrogate endpoints | ALONSO ABAD, Ariel; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; RENARD, Didier; GEYS, Helena; SHKEDY, Ziv; TIBALDI, Fabian; CORTINAS ABRAHANTES, Jose; BUYSE, Marc | Journal Contribution | A1 |
| 71 | 2004 | A perspective on surrogate endpoints in controlled clinical trials | MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel; BUYSE, Marc | Journal Contribution | A1 |
| 72 | 2004 | Five-year immunological outcome of highly active antiretroviral treatment in a clinical setting: results from a single HIV treatment centre | SCHROOTEN, Ward; Florence, E; DREEZEN, Caroline; Van Esbroeck, M; Fransen, K; ALONSO ABAD, Ariel; Desmet, R.; Colebunders, R; Kestens, L; De Roo, A | Journal Contribution | A1 |
| 73 | 2004 | Validation of surrogate markers in multiple randomized clinical trials with repeated measurements: Canonical correlation approach | ALONSO ABAD, Ariel; GEYS, Helena; MOLENBERGHS, Geert; Kenward, Michael G.; VANGENEUGDEN, Tony | Journal Contribution | A1 |
| 74 | 2004 | Choice of units of analysis and modeling strategies in multilevel hierarchical models | CORTINAS ABRAHANTES, Jose; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; SHKEDY, Ziv; ALONSO ABAD, Ariel; RENARD, Didier | Journal Contribution | A1 |
| 75 | 2003 | Validation of surrogate markers in multiple randomized clinical trials with repeated measures | ALONSO ABAD, Ariel; GEYS, Helena; MOLENBERGHS, Geert; Kenward, Michael G.; VANGENEUGDEN, Tony | Journal Contribution | A1 |
| 76 | 2002 | Use of multivariate extensions of generalized linear models in the analysis of data from clinical trials | ALONSO ABAD, Ariel; Rodriguez, O.; TIBALDI, Fabian; CORTINAS ABRAHANTES, Jose | Journal Contribution | A2 |